Site position #105
My
MyDrHank advertises compounded tablets and injections, but its GLP-1 landing page and separate product pages show different starting prices; get one written offer before choosing a term.
Our take
MyDrHank is worth a price inquiry, but we would obtain a written prescription quote before choosing a term. Its GLP-1 landing page advertises semaglutide from $171 and tirzepatide from $200 monthly, while the separate injection pages display $178 and $240. The reviewed pages do not explain that difference well enough to recommend a prepayment.
Is it for you?Best fit and reasons to look elsewhere
- Best for
- People comparing compounded tablets with weekly injections who are willing to confirm the exact formulation, payment schedule and dispensing pharmacy before enrolling.
- Look elsewhere if
- People who need a settled total and explicit unused-prepayment refund terms before making a decision, or who want the dispensing pharmacy and treating practice identified upfront.
- Semaglutide
- From $171/mo oral or injectable on GLP-1 lander; injection product page from $178/mo (conflicting offer terms; confirm)
- Tirzepatide
- From $200/mo on GLP-1 lander; product page from $240/mo (conflicting offer terms; confirm)
- Coverage
- Confirm prescription and state; contiguous-U.S. shipping claim does not establish individual eligibility
- Brand-name
- Not confirmed
In this review
Weigh MyDrHank against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.
The current site's base product data lists monthly totals of $249 for oral semaglutide, $259 for injectable semaglutide and $349 for tirzepatide, alongside longer-term totals. These are published application data, not verified patient invoices or an explanation of the lower landing-page offers.
The advertised price changes with the page
The GLP-1 landing page shows injectable semaglutide starting at $171 monthly and tirzepatide at $200. We also opened the separate product pages, where the selected B12 injection presentations showed starting figures of $178 and $240. The oral page showed $171 for its selected semaglutide-and-ondansetron tablet. These are actual public displays reviewed on October 25, 2026.
A different promotion or treatment arrangement could explain the lower offer. The pages we reviewed did not establish that explanation. Ask which formulation and commitment qualify, the amount charged today and the amount due next. We would not call an advertised offer unavailable merely because it differs from another page.
Longer terms reduce the equivalent, not necessarily the commitment
The current site's product data lists semaglutide injection totals of $259 monthly, $660 quarterly, $1,189 for six months and $2,140 yearly. Tirzepatide lists $349, $890, $1,602 and $2,883 for those terms. The displayed yearly equivalents are $178 and $240, matching the separate injection-page starting figures. That match does not establish the terms of the landing-page promotion.
For a conditional six-month comparison, six $259 charges total $1,554, versus the $1,189 six-month field; six $349 charges total $2,094, versus $1,602. Those differences are $365 and $492. They assume the published fields apply to your prescription and exclude unresolved charges. Ask when the full term is charged, how medication is supplied and what happens to unused months before treating a lower equivalent as a saving.
Get the full formula and quantity in the quote
The injection pages offer B12 and glycine selections. The oral page opens on a semaglutide-and-ondansetron preparation and also offers a separate tablet selection. Its current data contains another warning against guessing: that tablet variant has a monthly total field of $399 and a monthly-equivalent field of $329. We did not establish which would be charged.
Request the actual ingredients, prescribed dose, concentration, number of tablets or vials and usable supply period together. A photograph or familiar molecule name does not settle those details. The product pages disclose that their compounded preparations are not FDA-approved; the trial results displayed beside them should not be read as outcomes established for the selected compounded product.
Separate included support from an individual care plan
The product pages advertise free consultation and delivery, a dedicated clinical team, regular check-ins, dose adjustments and unlimited clinical messaging. Those inclusions may appeal to someone wanting continuing contact rather than a medication-only purchase. We have not used that support or measured its response times.
Ask who handles a medication concern, how to reach the prescriber, what routine review is scheduled and what happens outside normal hours. Establish whether any laboratory tests are required and who pays for them. The reviewed material did not supply a complete individual testing budget. Included messaging is useful only when you understand the clinical contact behind it.
The exit terms need to be settled before a prepayment
The landing page promotes cancellation at any time. Its cost FAQ says the price does not rise with the dose, while its pricing disclosure says the final amount depends on medication, dose and treatment plan and may change. Get the continuation rate and renewal interval for the offer you are actually considering.
The May 29, 2026 Terms of Use we reviewed do not give a GLP-1 cancellation deadline, a refund calculation for unused prepaid months or a clear financial outcome if treatment is declined. That leaves important questions open; it does not prove a refund is impossible. Ask for the applicable purchase policy and a specific example of stopping after the first shipment. Keep the answer alongside the payment authorization.
The platform is named; your actual care team still needs a name
The legal pages identify Dr. Hank, LLC as the platform operator. The privacy policy describes forwarding requests to, or nominating, licensed healthcare providers. The terms say using the service does not create a provider-patient relationship with Dr. Hank itself. We did not establish the assigned medical practice or individual prescriber from these public documents.
Obtain both names and verify the individual clinician for the state where you receive care. A company identity is not a professional license. The terms limit service to the United States, and the landing page describes shipping within the contiguous United States; neither establishes that a particular prescription is available in every state. Confirm medication eligibility and shipping address together.
Ask for the dispensing pharmacy before relying on the description
The terms say a current pharmacy-partner list is available on request. That is a clear next step, but the reviewed documents do not identify which legal entity and address would dispense your prescription. The general description of U.S. pharmacies is not enough to check a specific facility.
Request the assigned dispenser, its location and the pharmacist's contact information. Then check the relevant state records against that exact identity. We have not independently verified a current dispensing license or an assigned prescriber's license for this purchase. A reassuring pharmacy category or registration description cannot resolve an unnamed dispenser.
Our recommendation depends on the written offer
MyDrHank's choice of tablets and injections makes it a reasonable inquiry for someone comparing routes and formulations. We would proceed to a decision only after receiving one consistent quote covering the selected preparation, supply, next charges, pharmacy and exit terms. Someone choosing mainly for a low monthly figure should continue comparing while those answers remain open.
GLP-1 Scorecard reviewed the public landing page, product pages, legal documents and current published price data on October 25, 2026. We did not enroll, submit health information, buy medication or observe treatment outcomes. This assessment concerns what the offer establishes before purchase; a polished website and a familiar trial number do not establish the care an individual will receive.
Factor breakdown
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.
Strengths
- Public landing and product pages show starting prices before medical intake
- Compounded injection options and a separate oral semaglutide menu are advertised, with formulation differences to discuss with the prescriber
- Product pages advertise consultation, delivery, check-ins and unlimited clinical messaging; response times were not tested
- Terms identify the platform operator and offer the current pharmacy-partner list on request
What to consider
- The GLP-1 lander shows $171/$200 injectable starting rates, while separate injection pages show $178/$240; applicable purchase terms remain unresolved
- Published base plan fields do not establish that a particular promotion is unavailable or what an individual will actually pay
- The reviewed GLP-1 terms did not establish the cancellation cutoff, unused-prepayment refund formula or declined-treatment financial outcome
- The assigned medical practice, prescriber and dispensing location remain unestablished; no current individual license verification is claimed
- Dose, concentration, usable supply, laboratory costs and state-specific availability require confirmation
- Compounded preparations are not FDA-approved; displayed branded-product trial results do not establish outcomes for these formulations
Bottom line — Grade C
Site position #105 of 540. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.
Closest here
The rankings grading nearest MyDrHank — the realistic shortlist.
Go Vida Plena is a Spanish-first, Latino-focused medical weight-loss program offering GLP-1 therapy from $199/month, based in Utah.
Goldspan Health runs one plan per molecule with no tier ladder, bills every 28 days rather than monthly, and requires a lab panel it never prices.
Telehealth wellness clinic offering GLP-1 medications on a 4-week billing cycle.
WeightlessRx pairs three-month medication packages with nutrition coaching and clinician messaging, but monthly-billing and refund clauses need clarification before enrollment.
Membership and medication are separate purchases; compare the complete charges before choosing.
Factor scores not reassessed.FitFlow (FitFlow Health) is a 100% online compounded telehealth platform for GLP-1 weight loss - compounded semaglutide (=Wegovy) and tirzepatide (=Mounjaro).
The 24 rankings nearest this one
- #106 Luci71
- #107 Heally70.9
- #108 Layla70.9
- #109 DrBrainRx70.8
- #110 Edessa70.8
- #111 Longevixx70.7
- #112 NuuVim70.6
- #113 TRYM Health70.6
- #114 AlyveRx70.5
- #115 Good Life Meds70.5
- #116 The Edit70.4
- #117 eMI Aesthetics70.3
- #118 RedBox Rx70.2
- #119 Rex MD70.2
- #120 Kina70.1
- #121 OnlineSemaglutide.org70.1
- #122 YOURx Health70
- #123 Remote Pharmacy69.9
- #124 Alternate Health Club69.8
- #125 Navio MD69.8
- #126 Ageless69.7
- #127 Bon Health69.7
- #128 Heva Health69.7
- #129 Livea69.7
Prices and terms can change; confirm them with MyDrHank. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.